Former Lynx CEO Resurfaces at Helm of Biochip Startup Company Aviva Biosciences | GenomeWeb

Norrie Russell turned 50 last week and got a job. Sounds like a milestone week. Well, the part about hitting 50 years old — “going to the other side” he described it — wasn’t all that exciting, said Russell in a telephone interview on his second day at work at Aviva Biosciences of San Diego. But, the part about getting a job as chief executive officer and president at an early-stage biochip company, with several promising products in the pipeline, that was really exciting, he said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.